Trial site
NHO Shikoku Cancer Center
- 16running trials
- 7closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Gastric and oesophageal cancer6 trials
- Colorectal cancer3 trials
- Metastatic breast cancer3 trials
- Ovarian cancer3 trials
- Cervical cancer2 trials
- Chronic lymphocytic leukaemia2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 315 trials
- Phase 26 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting11 trials
- Recruiting5 trials
- Completed4 trials
- Terminated3 trials
- Lead sponsor
- Daiichi Sankyo8 trials
- Seagen, a wholly owned subsidiary of Pfizer4 trials
- BeOne Medicines2 trials
- Asahi Kasei Therapeutics, Inc.1 trial
- AstraZeneca1 trial
- and 7 more
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Recruiting
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer3 recruiting
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Terminated
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026